Implantable Drug Delivery Devices Market Trend 2020: Covid-19 Impact to Showing Impressive Growth by 2030 | Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research

The Business Research Company offers "Implantable Drug Delivery Devices Global Market Report 2020-30: COVID 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The global implantable drug delivery devices market is expected to decline from $19.18 billion in 2019 to $18.82 billion in 2020 at a compound annual growth rate (CAGR) of -3.38%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $24.14 billion in 2023 at a CAGR of 8.65%.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3303

The implantable drug delivery devices market consists of sales of implantable drug delivery devices and related services by companies that manufacture them. Implantable drug delivery devices are drug delivery systems implanted by surgery to allow site-specific drug administration at the tissue or organ where the drug is most needed.

The rise in the incidence of target diseases such as diabetic retinopathy, cancer, cardiovascular diseases and other chronic diseases is expected to drive the implantable drug delivery devices market. According to the International Diabetes Federation (IDF), the global prevalence of diabetic retinopathy was around 27% between 2015 and 2019. Implantable drug delivery devices are used for site-specific drug administration where the drug is most needed, such as Gliadel® wafer as an implant used in the treatment of brain tumors, Lupron® depot for the treatment of prostate cancer. Hence, due to the site-specific drug administration nature of implantable drug devices, which help in the treatment of target diseases, is driving the implantable drug delivery devices market.

Implantable Drug Delivery Devices Market Segmentation:
By Product
1.Contraceptive Implants
2.Spinal Implants
3.Brachytherapy Seeds
4.Drug-Eluting Stents
5.Bio-absorbable Stents
6.Intraocular Stents
7.Infusion Pumps and Others

By Technology
1.Diffusion
2.Osmotic
3.Magnetic and Others
By Application
1.Contraception
2.Ophthalmology
3.Cardiovascular
4.Diabetes
5.Oncology
6.Autoimmune Diseases and Others

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report-2020-30-covid-19-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Implantable Drug Delivery Devices Market Characteristics
3. Implantable Drug Delivery Devices Market Size And Growth
4. Implantable Drug Delivery Devices Market Segmentation
5. Implantable Drug Delivery Devices Market Regional And Country Analysis
....
25. Implantable Drug Delivery Devices Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Implantable Drug Delivery Devices Market
27. Implantable Drug Delivery Devices Market Trends And Strategies
28. Implantable Drug Delivery Devices Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the implantable drug delivery devices market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3303&type=smp

Some of the key players involved in the Implantable Drug Delivery Devices Market are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc, Merck, Genetech Inc., Psivida, Nucletron.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.